Biotech Biz Buys COVID Test Kit Maker For £10.4M
Biotechnology company Avacta announced Thursday that it has acquired test kit maker Coris Bioconcept for up to £10.4 million ($12.5 million) to expand its diagnostics division....To view the full article, register now.
Already a subscriber? Click here to view full article